Sarepta Therapeutics (SRPT) Long-Term Debt Repayments (2010 - 2025)
Sarepta Therapeutics' quarterly Long-Term Debt Repayments came in at $35.1 million in Q4 2025, up 116.14% quarter-over-quarter from -$217.4 million in Q4 2018.
Sarepta Therapeutics has reported Long-Term Debt Repayments for 10 years, with the latest figure at $35.1 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to $35.1 million; the trailing twelve-month figure through Dec 2025 stood at $35.1 million (changed N/A YoY), and the FY2025 full-year result was $158.4 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q4 2025 stood at $35.1 million, up from -$217.4 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $35.1 million in Q4 2025, with the low at $35.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.09 Mn |
| Dec 31, 2025 | 35.09 Mn |
| Dec 31, 2018 | -217.37 Mn |
| Dec 31, 2018 | -217.37 Mn |
| Sep 30, 2018 | 44.98 Mn |
| Sep 30, 2018 | 44.98 Mn |
| Jun 30, 2018 | 172.39 Mn |
| Jun 30, 2018 | 172.39 Mn |
| Mar 31, 2018 | 1.27 Mn |
| Mar 31, 2018 | 1.27 Mn |
| Dec 31, 2017 | 16.64 Mn |
| Dec 31, 2017 | 16.64 Mn |
| Sep 30, 2017 | 17.95 Mn |
| Sep 30, 2017 | 17.95 Mn |
| Jun 30, 2017 | 5.01 Mn |
| Jun 30, 2017 | 5.01 Mn |
| Mar 31, 2017 | 43,000.00 |
| Mar 31, 2017 | 43,000.00 |
| Dec 31, 2016 | -2.47 Mn |
| Dec 31, 2016 | -2.47 Mn |
| Sep 30, 2016 | 2.53 Mn |
| Sep 30, 2016 | 2.53 Mn |
| Jun 30, 2016 | 26,000.00 |
| Jun 30, 2016 | 26,000.00 |
| Mar 31, 2016 | 2.53 Mn |
| Mar 31, 2016 | 2.53 Mn |
| Dec 31, 2015 | 25,000.00 |
| Dec 31, 2015 | 25,000.00 |
| Sep 30, 2015 | 2.52 Mn |
| Sep 30, 2015 | 2.52 Mn |
| Jun 30, 2015 | 24,000.00 |
| Jun 30, 2015 | 24,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Dec 31, 2014 | 24,000.00 |
| Dec 31, 2014 | 24,000.00 |
| Sep 30, 2014 | 23,000.00 |
| Sep 30, 2014 | 23,000.00 |
| Jun 30, 2014 | 24,000.00 |
| Jun 30, 2014 | 24,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 22,000.00 |
| Dec 31, 2013 | 22,000.00 |
| Sep 30, 2013 | 22,000.00 |
| Sep 30, 2013 | 22,000.00 |
| Jun 30, 2013 | 23,000.00 |
| Jun 30, 2013 | 23,000.00 |
| Mar 31, 2013 | 22,000.00 |
| Mar 31, 2013 | 22,000.00 |
| Dec 31, 2012 | 21,000.00 |
| Dec 31, 2012 | 21,000.00 |
| Sep 30, 2012 | 22,000.00 |
| Sep 30, 2012 | 22,000.00 |
| Jun 30, 2012 | 21,000.00 |
| Jun 30, 2012 | 21,000.00 |
| Mar 31, 2012 | 21,000.00 |
| Mar 31, 2012 | 21,000.00 |
| Dec 31, 2011 | 20,000.00 |
| Dec 31, 2011 | 20,000.00 |
| Sep 30, 2011 | 21,000.00 |
| Sep 30, 2011 | 21,000.00 |
| Jun 30, 2011 | 20,000.00 |
| Jun 30, 2011 | 20,000.00 |
| Mar 31, 2011 | 20,000.00 |
| Mar 31, 2011 | 20,000.00 |
| Dec 31, 2010 | 19,000.00 |
| Dec 31, 2010 | 19,000.00 |
| Sep 30, 2010 | 19,000.00 |
| Sep 30, 2010 | 19,000.00 |